81 related articles for article (PubMed ID: 9388953)
1. [Tolerance to rat parathyroid allograft induced by depletion of Ia+ donor cells plus short course cyclosporine].
Zhang TP; Zhu Y; Wang S; Guan H; Tang W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1996 Dec; 18(6):457-60. PubMed ID: 9388953
[TBL] [Abstract][Full Text] [Related]
2. Indefinite survival of rat parathyroid allografts without postoperative immunosuppression.
Bloom AD; Economou SG; Gebel HM
Surgery; 1986 Dec; 100(6):1032-8. PubMed ID: 3491436
[TBL] [Abstract][Full Text] [Related]
3. Short-term immunosuppression after rat parathyroid allotransplantation.
Timm S; Otto C; Begrich D; Illert B; Hamelmann W; Ulrichs K; Thiede A; Timmermann W
Microsurgery; 2003; 23(5):503-7. PubMed ID: 14558011
[TBL] [Abstract][Full Text] [Related]
4. Extension of survival of rat parathyroid allografts by depletion of Ia donor cells plus preoperative cyclosporine.
Bloom AD; Economou SG; Gebel HM
Transplantation; 1987 Aug; 44(2):171-4. PubMed ID: 3307039
[TBL] [Abstract][Full Text] [Related]
5. Donor-specific tolerance in fully major histocompatibility major histocompatibility complex-mismatched limb allograft transplants under an anti-alphabeta T-cell receptor monoclonal antibody and cyclosporine A protocol.
Siemionow MZ; Izycki DM; Zielinski M
Transplantation; 2003 Dec; 76(12):1662-8. PubMed ID: 14688512
[TBL] [Abstract][Full Text] [Related]
6. Depletion of donor Ia+ cells before transplantation does not prolong islet allograft survival.
Gores PF; Sutherland DE; Platt JL; Bach FH
J Immunol; 1986 Sep; 137(5):1482-5. PubMed ID: 3091683
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine dosage can be reduced when used in combination with an anti-intercellular adhesion molecule-1 monoclonal antibody in rats undergoing heterotopic heart transplantation.
Harrison PC; Mainolfi E; Madwed JB
J Heart Lung Transplant; 1998 Feb; 17(2):150-7. PubMed ID: 9513853
[TBL] [Abstract][Full Text] [Related]
8. Effect of immunosuppression on outcome measures in a model of rat limbal transplantation.
Mills RA; Coster DJ; Williams KA
Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):647-55. PubMed ID: 11867579
[TBL] [Abstract][Full Text] [Related]
9. A short course of cyclosporine immunosuppression inhibits rejection but not tolerance of rat liver allografts.
Huang WH; Yan Y; De Boer B; Bishop GA; House AK
Transplantation; 2003 Feb; 75(3):368-74. PubMed ID: 12589161
[TBL] [Abstract][Full Text] [Related]
10. Role of thymus in operational tolerance induction in limb allograft transplant model.
Siemionow M; Izycki D; Ozer K; Ozmen S; Klimczak A
Transplantation; 2006 Jun; 81(11):1568-76. PubMed ID: 16770246
[TBL] [Abstract][Full Text] [Related]
11. Effect of immunosuppression on survival of allograft limbal stem cells.
Chen W; Cao L; Hara K; Yoshitomi T
Jpn J Ophthalmol; 2004; 48(5):440-7. PubMed ID: 15486765
[TBL] [Abstract][Full Text] [Related]
12. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
13. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate.
Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW
J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107
[TBL] [Abstract][Full Text] [Related]
14. [Prolongation of corneal allograft survival in mice with a cyclosporine drug delivery system implant].
Shi W; Xie L; Wang S
Zhonghua Yan Ke Za Zhi; 2002 Aug; 38(8):502-5. PubMed ID: 12410993
[TBL] [Abstract][Full Text] [Related]
15. Flt-3 ligand increases microchimerism but can prevent the therapeutic effect of donor bone marrow in transiently immunosuppressed cardiac allograft recipients.
Antonysamy MA; Steptoe RJ; Khanna A; Rudert WA; Subbotin VM; Thomson AW
J Immunol; 1998 Apr; 160(8):4106-13. PubMed ID: 9558122
[TBL] [Abstract][Full Text] [Related]
16. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival of limb allografts induced by pharmacologically conditioned, donor alloantigen-pulsed dendritic cells without maintenance immunosuppression.
Ikeguchi R; Sacks JM; Unadkat JV; Solari M; Horibe EK; Thomson AW; Lee AW; Feili-Hariri M
Transplantation; 2008 Jan; 85(2):237-46. PubMed ID: 18212629
[TBL] [Abstract][Full Text] [Related]
18. Transplantation of parathyroid, adrenal cortex and adrenal medulla using procedures which successfully prolonged islet allograft survival.
Ricordi C; Lacy PE; Santiago JV; Cryer PE; di Carlo V
Horm Metab Res Suppl; 1990; 25():132-5. PubMed ID: 2088953
[TBL] [Abstract][Full Text] [Related]
19. A synthetic CD4-CDR3 peptide analog enhances skin allograft survival across a MHC class II barrier.
Koch U; Choksi S; Marcucci L; Korngold R
J Immunol; 1998 Jul; 161(1):421-9. PubMed ID: 9647252
[TBL] [Abstract][Full Text] [Related]
20. Long-term limb allograft survival using a short course of anti-CD45RB monoclonal antibody, LF 15-0195, and rapamycin in a mouse model.
Zhong T; Liu Y; Jiang J; Wang H; Temple CL; Sun H; Garcia B; Zhong R; Ross DC
Transplantation; 2007 Dec; 84(12):1636-43. PubMed ID: 18165776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
